Merck KGaA (MRK) Given a €116.00 Price Target by BNP Paribas Analysts
Merck KGaA (FRA:MRK) has been assigned a €116.00 ($138.10) price target by equities research analysts at BNP Paribas in a research report issued on Wednesday. The firm currently has a “buy” rating on the healthcare company’s stock.
MRK has been the topic of several other reports. equinet AG set a €91.00 ($108.33) price objective on Merck KGaA and gave the company a “neutral” rating in a research report on Saturday, May 20th. DZ Bank AG reissued a “neutral” rating on shares of Merck KGaA in a research report on Saturday, May 20th. Warburg Research set a €116.00 ($138.10) price objective on Merck KGaA and gave the company a “neutral” rating in a research report on Tuesday, June 20th. J P Morgan Chase & Co reissued a “neutral” rating on shares of Merck KGaA in a research report on Friday, August 4th. Finally, Deutsche Bank AG set a €106.00 ($126.19) price objective on Merck KGaA and gave the company a “neutral” rating in a research report on Friday, August 4th. Fourteen investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of €107.71 ($128.23).
Merck KGaA (FRA MRK) traded up 0.022% during midday trading on Wednesday, hitting €95.623. The company had a trading volume of 1,786 shares. The stock has a 50 day moving average of €93.50 and a 200 day moving average of €102.64. The firm has a market cap of €41.57 billion and a price-to-earnings ratio of 24.928. Merck KGaA has a 52-week low of €89.00 and a 52-week high of €115.00.
TRADEMARK VIOLATION NOTICE: This article was first posted by American Banking News and is the property of of American Banking News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US and international copyright laws. The original version of this article can be read at https://www.americanbankingnews.com/2017/09/10/merck-kgaa-mrk-given-a-116-00-price-target-by-bnp-paribas-analysts.html.
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.